Call Us : +917383797038
Gemcitabine Injection IP 1gm

Gemcitabine Injection IP 1gm

Product Details:

  • Drug Type Generic Drugs
  • Ingredients Gemcitabine 1 gm
  • Physical Form Liquid
  • Function Anti-Cancer
  • Recommended For Cancer Treatment
  • Dosage injection
  • Dosage Guidelines As guided by physician
  • Supply Ability : 10000 Vial, , Per Month
  • Click to view more

Price And Quantity

  • 1000 INR
  • 1 Vial, ,

Product Specifications

  • As guided by physician
  • 2C to 8C cold storage
  • Generic Drugs
  • 1gm Unit
  • Cancer Treatment
  • injection
  • Anti-Cancer
  • Liquid
  • Gemcitabine 1 gm

Trade Information

  • Delhi, Mumbai
  • Paypal, Western Union, Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Cheque, Cash in Advance (CID), Cash Advance (CA)
  • 10000 Vial, , Per Month
  • 7 Days
  • Per pack 1 vial
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • All India

Product Description

Gemcitabine 1000mg

Name of the Medicinal Product

Gemcitabine 1000 Mg, Powder for Solution for Infusion

Qualitative and Quantitative Composition

Each Vial Contains 1000 Mg Gemcitabine (as Hydrochloride)

Excipients With Known Effect:
  • Each Vial Contains 17.5 Mg Sodium.
  • One Ml of the Reconstituted Solution for Infusion Contains 38 Mg Gemcitabine (as Hydrochloride).
  • Pharmaceutical Form
  • Powder for Solution Infusion.
  • White to Off-white Lyophilized Cake.
Clinical Particulars

Gemcitabine Is Indicated for the Treatment of Locally Advanced or Metastatic Bladder Cancer in Combination With Cisplatin.

Gemcitabine Is Indicated for Treatment of Patients With Locally Advanced or Metastatic Adenocarcinoma of the Pancreas.

Gemcitabine, in Combination With Cisplatin Is Indicated as First Line Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (Nsclc). Gemcitabine Monotherapy Can Be Considered in Elderly Patients or Those With Performance Status 2.

Gemcitabine Is Indicated for the Treatment of Patients With Locally Advanced or Metastatic Epithelial Ovarian Carcinoma, in Combination With Carboplatin, in Patients With Relapsed Disease Following a Recurrence-free Interval of at Least 6 Months After Platinum-based, First-line Therapy.

Gemcitabine, in Combination With Paclitaxel, Is Indicated for the Treatment of Patients With Unresectable, Locally Recurrent or Metastatic Breast Cancer Who Have Relapsed Following Adjuvant/neoadjuvant Chemotherapy. Prior Chemotherapy Should Have Included an Anthracycline Unless Clinically Contraindicated.


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.